The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma.
 
Daniela Matei
Honoraria - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Genentech/Roche
Consulting or Advisory Role - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Roche/Genentech
Research Funding - Merck; Merck
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche
 
Virginia L. Filiaci
No Relationships to Disclose
 
Marcus Randall
No Relationships to Disclose
 
Margaret Steinhoff
No Relationships to Disclose
 
Paul DiSilvestro
Research Funding - AstraZeneca (Inst); Genentech (Inst); ImmunoGen (Inst); Janssen (Inst); Pfizer (Inst); Tesaro (Inst)
Expert Testimony - Johnson & Johnson
 
Katherine M. Moxley
No Relationships to Disclose
 
Byoung Kim
No Relationships to Disclose
 
Matthew A. Powell
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
Speakers' Bureau - AstraZeneca; Genentech/Roche
 
David M. O'Malley
Honoraria - Clovis Oncology
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Eisai; Genentech/Roche; Janssen Oncology; Novocure; Tesaro
Research Funding - Ajinomoto (Inst); Amgen (Inst); Array BioPharma (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Clovis Oncology (Inst); EMD Serono (Inst); Ergomed (Inst); Genentech/Roche (Inst); Immunogen (Inst); Immunogen (Inst); Janssen Research & Development (Inst); PharmaMar (Inst); Regeneron (Inst); Stem CentRx (Inst); VentiRx (Inst)
 
Nicola M. Spirtos
No Relationships to Disclose
 
Krishnansu Sujata Tewari
Consulting or Advisory Role - Roche/Genentech
Speakers' Bureau - AstraZeneca; Merck; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Wm Edward Richards
No Relationships to Disclose
 
John Nakayama
Honoraria - Medscape; ZoomRx
 
David Gardner Mutch
Consulting or Advisory Role - lilly
Speakers' Bureau - AstraZeneca
 
David S. Miller
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genentech; Janssen
Speakers' Bureau - Clovis Oncology; Genentech
Research Funding - Aeterna Zentaris (Inst); AstraZeneca (Inst); Janssen (Inst); Tesaro (Inst); TRACON Pharma (Inst); Vermillion (Inst)